Hosted on MSN20h
Biocurious: No sweat as Botanix tackles the world’s third-biggest skin disorder
Botanix's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating. ... Read ...
Finanznachrichten22h
The Insight Partners: Botulinum Toxin Market Analysis by Size, Share, and Growth | Market Value 19.03 Billion by 2031 at 12.6% CAGR
This type is also used in treating incontinence, migraine, hyperhidrosis, and blepharospasm. Its cosmetic applications include the reduction of wrinkles and fine lines on the face, especially wrinkles ...
dermatologyadvisor22h
Primary Hyperhidrosis Is Linked to an Increased Risk for Anxiety, Depression
Adults with primary hyperhidrosis had an increased risk for anxiety and depression when compared with those without primary hyperhidrosis.